These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 2269683

  • 1. Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors.
    Kayalar C, Wong WT, Hendrickson L.
    J Cell Biochem; 1990 Nov; 44(3):137-51. PubMed ID: 2269683
    [Abstract] [Full Text] [Related]

  • 2. Metalloendoprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme.
    Kayalar C, Wong WT.
    J Biol Chem; 1989 May 25; 264(15):8928-34. PubMed ID: 2656690
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor binding protein secretion by muscle cells: effect of cellular differentiation and proliferation.
    McCusker RH, Clemmons DR.
    J Cell Physiol; 1988 Dec 25; 137(3):505-12. PubMed ID: 2461381
    [Abstract] [Full Text] [Related]

  • 5. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM, Bennett RG, Siford GL, Hamel FG.
    Biochem Pharmacol; 2009 Mar 15; 77(6):1064-73. PubMed ID: 19154729
    [Abstract] [Full Text] [Related]

  • 6. Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-alpha.
    Halevy O, Lerman O.
    J Cell Physiol; 1993 Mar 15; 154(3):566-72. PubMed ID: 8382210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of insulin degradation by insulin-like growth factors.
    Misbin RI, Almira EC, Duckworth WC, Mehl TD.
    Endocrinology; 1983 Oct 15; 113(4):1525-7. PubMed ID: 6352249
    [Abstract] [Full Text] [Related]

  • 9. Effect of insulin-like growth factor (IGF)-I and Des (1-3) IGF-I on the level of IGF binding protein-3 and IGF binding protein-3 mRNA in cultured porcine embryonic muscle cells.
    Yang F, Johnson BJ, White ME, Hathaway MR, Dayton WR.
    J Cell Physiol; 1999 Feb 15; 178(2):227-34. PubMed ID: 10048587
    [Abstract] [Full Text] [Related]

  • 10. Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells.
    Olson EN, Caldwell KL, Gordon JI, Glaser L.
    J Biol Chem; 1983 Feb 25; 258(4):2644-52. PubMed ID: 6337159
    [Abstract] [Full Text] [Related]

  • 11. The soluble metalloendoprotease required in myoblast fusion remains intracellular.
    Farach HA, Strittmatter WJ.
    Biochem Biophys Res Commun; 1987 Aug 31; 147(1):474-8. PubMed ID: 3307780
    [Abstract] [Full Text] [Related]

  • 12. Control of muscle differentiation in BC3H1 cells by fibroblast growth factor and vanadate.
    Wice B, Milbrandt J, Glaser L.
    J Biol Chem; 1987 Feb 05; 262(4):1810-7. PubMed ID: 3643214
    [Abstract] [Full Text] [Related]

  • 13. The expression of sarcomeric muscle-specific contractile protein genes in BC3H1 cells: BC3H1 cells resemble skeletal myoblasts that are defective for commitment to terminal differentiation.
    Taubman MB, Smith CW, Izumo S, Grant JW, Endo T, Andreadis A, Nadal-Ginard B.
    J Cell Biol; 1989 May 05; 108(5):1799-806. PubMed ID: 2715180
    [Abstract] [Full Text] [Related]

  • 14. Specific blockers of myoblast fusion inhibit a soluble and not the membrane-associated metalloendoprotease in myoblasts.
    Couch CB, Strittmatter WJ.
    J Biol Chem; 1984 May 10; 259(9):5396-9. PubMed ID: 6371004
    [Abstract] [Full Text] [Related]

  • 15. Rat myoblast fusion requires metalloendoprotease activity.
    Couch CB, Strittmatter WJ.
    Cell; 1983 Jan 10; 32(1):257-65. PubMed ID: 6337722
    [Abstract] [Full Text] [Related]

  • 16. Further characterization of BC3H1 myogenic cells reveals lack of p53 activity and underexpression of several p53 regulated and extracellular matrix-associated gene products.
    Sharp SB, Villalvazo M, Huang M, Gonzalez R, Alarcon I, Bahamonde M, D'Agostin DM, Damle S, Espinosa A, Han SJ, Liu J, Navarro P, Salguero H, Son J, Vu S.
    In Vitro Cell Dev Biol Anim; 2002 Jan 10; 38(7):382-93. PubMed ID: 12534338
    [Abstract] [Full Text] [Related]

  • 17. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.
    Spizz G, Roman D, Strauss A, Olson EN.
    J Biol Chem; 1986 Jul 15; 261(20):9483-8. PubMed ID: 3722206
    [Abstract] [Full Text] [Related]

  • 18. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
    Duckworth WC, Hamel FG, Bennett R, Ryan MP, Roth RA.
    J Biol Chem; 1990 Feb 15; 265(5):2984-7. PubMed ID: 1689296
    [Abstract] [Full Text] [Related]

  • 19. Control by fibroblast growth factor of differentiation in the BC3H1 muscle cell line.
    Lathrop B, Olson E, Glaser L.
    J Cell Biol; 1985 May 15; 100(5):1540-7. PubMed ID: 3988800
    [Abstract] [Full Text] [Related]

  • 20. Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes.
    Jochen A, Berhanu P.
    Biochem Biophys Res Commun; 1987 Jan 15; 142(1):205-12. PubMed ID: 3545203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.